2016年6月23日 · Patients with negative PET findings after two cycles were randomly assigned to continue ABVD (ABVD group) or omit bleomycin (AVD group) in cycles 3 through 6. Those …

2019年1月15日 · PET done after two courses of chemotherapy (PET2) can predict progression-free survival 10,11 with a negative predictive value of 98% in patients treated with BEACOPP …

2019年12月13日 · Patients with positive interim PET after 2 cycles of first-line therapy (iPET2) had a 5-time increased risk of unfavorable outcome than iPET2-negative patients. …

2019年10月10日 · Early PET response–adapted ABVD-based therapy for aHL results in improved outcomes for early interim PET-positive patients and in excellent overall outcomes (94% 5 …

For patients age 60 or younger without comorbidities who are able to tolerate aggressive treatment, initial therapy with two cycles escBEACOPP regimen followed by de-escalation to …

2024年11月5日 · PET-directed therapy using ABVD with or without radiation therapy (RT) is considered standard in early stage classic Hodgkin lymphoma (cHL). Brentuximab vedotin …

2023年5月1日 · The Italian Lymphoma Group HD0801 study employed a more thorough approach by escalating patients who were PET positive after 2 cycles of ABVD (DS of 3-5). 7 …

2016年5月19日 · Patients received two cycles of ABVD followed by a PET-CT with central review. 28 Those with a PET-2–negative scan (82% of patients) defined as Deauville 1–3 continued …

We assessed the significance of interim positron emission tomography (iPET) scan after 2 cycles (iPET2) in identifying this high-risk subset. Patients and methods: This cohort study used …

Introduction: Positron emission tomography-computed tomography (PET-CT) performed after two chemotherapy cycles (PET-2) has become an accepted prognostic tool in Hodgkin lymphoma …